Latest News

Financial Times - Aug 23

The following are the top stories in the Financial Times. Reuters has not validated these stories and does not vouch for their accuracy.

Headings

- AstraZeneca threatens to move UK vaccine producing to US

- Alzheimer's drug authorized by UK regulator but too costly for NHS

- Nestlé chief executive Mark Schneider to step down

- Gatwick airport waits for approval to expand as service booms

- Deutsche Bank settles with 60% of claimants in more than decade-long Postbank case

Introduction

- AstraZeneca has actually warned it might relocate its vaccine manufacturing site from Merseyside to Philadelphia amid a deadlock in settlements with the UK Labour government over strategies to cut state aid assured to the task.

- A drug that can slow the decline in patients with early-stage Alzheimer's disease will not be available to NHS clients in England, the healthcare costs guard dog has ruled, in spite of the UK medicines regulator authorizing it.

- Nestlé revealed that president Mark Schneider was stepping down, and will be succeeded by company veteran Laurent Freixe, following a period of underperformance at the world's largest food maker.

- UK's Gatwick airport stated it has been experiencing among its busiest summers, as growing demand for air travel, along with brand-new long-haul routes, helped drive up guest growth by nearly 8% in the first half of the year.

- Deutsche Bank has reached settlements with 60%. of claimants in a more than decade-long conflict over its. acquisition of Postbank.

(source: Reuters)